Related Experiment Video
Updated: Jan 20, 2026
Comparison of Three Different Methods for Determining Cell Proliferation in Breast Cancer Cell Lines
Published on: September 3, 2016
Rasal2 suppresses breast cancer cell proliferation modulated by secretory autophagy
Xuan Wang1, Xuzhi Yin2, Yonghua Yang3
1Department of Pharmacology and Biochemistry, School of Pharmacy, Fudan University, Shanghai, 201203, China.
Abstract:
Rasal2, a Ras-GTPase-activating protein (RasGAP), is a tumor suppressor in Luminal B breast cancer, frequently metastatic and recurrent. Exosomes (Exos) are small membrane vesicles secreted by various cell types, including tumor cells, recognized as vehicles for cell-to-cell communication. Our study aimed to investigate whether Rasal2 regulates breast cancer cell growth via affecting this process. In this paper, we described that Rasal2 knockout (KO) in MCF-7 cells enhanced exosomal release and increased autophagy-related proteins in exosomal fraction, while attenuated by exosome release inhibitor GW4869. Moreover, MCF-7 cells with chloroquine (CQ) treatment boosted Rasal2 KO-induced secretory autophagy. In addition, we presented that exosomes derived from KO MCF-7 cells (KO-exo) significantly promoted breast cancer cell proliferation compared to those from MCF-7 cells transfected with an empty crispr-cas9 plasmid serving as controls (sgNT-exo); however, exosomes purified from KO MCF-7 cells co-cultured with 3-methyladenine ((3-MA + KO)-exo)/CQ ((CQ + KO)-exo) dramatically inhibited/facilitated MCF-7 cell proliferation in contrast to KO-exo group, separately. In conclusion, our findings revealed a new mechanism of Rasal2 in the regulation of breast cancer cell proliferation via autophagy-exo-mediated pathway.
Insights
Rasal2 deficiency enhances breast cancer cell communication through exosomes and autophagy. This Ras-GTPase-activating protein (RasGAP) impacts tumor growth via an autophagy-exosome pathway, revealing a novel therapeutic target for metastatic breast cancer.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Rasal2, a Ras-GTPase-activating protein (RasGAP), functions as a tumor suppressor in Luminal B breast cancer, a subtype prone to metastasis and recurrence.
- Exosomes (Exos) are critical mediators of intercellular communication, released by tumor cells and influencing cancer progression.
- The precise role of Rasal2 in regulating exosome release and its impact on breast cancer cell communication remains largely unexplored.
Purpose of the Study:
- To investigate the role of Rasal2 in regulating breast cancer cell growth by modulating exosome secretion and autophagy.
- To elucidate the mechanism by which Rasal2 influences intercellular communication in breast cancer via the autophagy-exosome pathway.
Main Methods:
- Rasal2 knockout (KO) was performed in MCF-7 breast cancer cells.
- Exosome release was assessed, with and without the exosome release inhibitor GW4869.
- Autophagy was modulated using chloroquine (CQ) and 3-methyladenine (3-MA).
- The effect of exosomes derived from Rasal2-modified cells on breast cancer cell proliferation was evaluated.
Main Results:
- Rasal2 KO in MCF-7 cells significantly enhanced exosomal release and increased autophagy-related proteins within the exosomal fraction.
- Exosomes derived from Rasal2 KO cells (KO-exo) promoted MCF-7 cell proliferation.
- Modulation of autophagy (using 3-MA or CQ) in KO cells altered the effect of their derived exosomes on proliferation, inhibiting or facilitating it, respectively.
Conclusions:
- Rasal2 plays a crucial role in regulating breast cancer cell proliferation through an autophagy-exosome-mediated pathway.
- Loss of Rasal2 function enhances tumor cell communication via exosomes, potentially contributing to breast cancer progression.
- This study uncovers a novel mechanism involving Rasal2, autophagy, and exosome secretion in breast cancer, suggesting potential therapeutic avenues.
Related Concept Videos
03:19Co-culturing BC Cells: Culturing Breast Cancer Cells with Bone Fragments to Study Cancer Cell Proliferation
12:35Comparison of Three Different Methods for Determining Cell Proliferation in Breast Cancer Cell Lines
09:22Invasive Behavior of Human Breast Cancer Cells in Embryonic Zebrafish
05:02Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
03:45ADI-based Autophagy Induction in Prostate Cancer Cells: An Enzyme-based Technique to Measure Autophagic Response in Cells
07:01Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors